As PD-L1 and PD1 are overexpressed in a subset of cancers and therapies to block these pathways have helped to reduce tumor burdens, expression of PD-L1 in KSHV-infected cells could be of great interest to reduce KSHV persistence and associated malignancies. Here, PDCD1 is linked to cancer.